Researchers at Glasgow University have discovered that ovarian cancer drug, olaparib, has the potential to treat patients with glioblastomas

Gideon Burrows has written his second book with personal stories, experiences, statistics and information, helped by a huge amount of people directly affected

The Wilderness Centre will host The Brain Tumour Charity’s Gloucestershire Family day next month as part of the charity’s commitment to supporting all those affected by this devastating disease.

A team of from Ian Williams’ Plymouth office took on a two day cycle challenge, raising £5000

A gene therapy to treat recurrent high-grade gliomas is accelerated to Phase 3 clinical trials, after the success of Phase 1 clinical trials by the US Food and Drug Administration (FDA)

Our Policy & Public Affairs Manager, Cameron Miller, on Australia’s Cure Brain Cancer AU$100m investment fund

A team of researchers at UCLA have discovered a combination of drugs to prevent the growth of glioblastomas, as well as kill tumour cells in mice with glioblastomas

Jonathan Canty, our Project Information Analyst, reflects on the SNP Conference in Glasgow last week

A research team at the University of Texas, led by Professor George Biros have been able to accurately characterise gliomas using a super computer

Professor Frank Winkler and his team at Heidelberg University in Germany have discovered a potential mechanism that could explain glioma recurrence

Our Policy & Public Affairs Manager Cameron Miller, reports from the Conservative Party Conference.

We were delighted to bring together a number of representatives from our incredible corporate partners to use their expertise to help us in our mission of defeating brain tumours.

Researchers at The Institute of Cancer Research identify new subgroups for high-grade glial tumours occurring in children

Our Policy & Public Affairs Manager, Cameron Miller, writes from the frontline of the party conference in Brighton

Researchers at Stanford University discover that the absence of a particular protein halts the growth of high-grade gliomas

A diffuse intrinsic pontine glioma (DIPG) diagnosis can be one of the most difficult things for a parent to hear, leaving families feeling helpless and desperately frustrated with the devastating prognosis.

Sarah Lindsell, The Charity’s Chief Executive, has co-signed a letter urging the Secretary of State for Health, Jeremy Hunt, to protect England’s largest annual survey of cancer patient experience in the NHS

We have awarded the Dutch/British WINDOW Consortium a grant of £1.5 million (€1.75 million) for research into Glioblastoma

A team of researchers investigated the effect of the Zika virus on glioblastoma cells in mice, as well as in human brain tissue samples. They discovered that the virus infected and killed the cancerous cells

Sarah Lindsell, our CEO, talks about why gifts in Wills should be in our everyday conversations…

As part of our commitment to improving life today for those affected by brain tumours, we’re excited to announce the expansion of our support offering as we roll out Live Chat

Communications Officer, Stephanie Layton, explores the progress of some of the exciting research Dr Darren Hargrave is currently working on.

We believe brain tumour patients need a ‘global Britain’ after Brexit. The UK Government has published an important paper outlining its current position on scientific cooperation for when the UK leaves the European Union

HeadSmart were ‘all fired up’ after learning from Saturdays’ singer Rochelle Humes they had been voted the UK’s favourite National Lottery funded health project.